Opus Genetics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Opus Genetics, Inc. on January 12, 2026. The report primarily serves to disclose a scheduled corporate presentation by management at the 44th Annual J.P. Morgan Healthcare Conference, set to occur on January 15, 2026.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of an upcoming event rather than a financial results report.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces the timing and availability of a corporate presentation.
Guidance, Outlook, and Management Commentary
Management will deliver a corporate presentation at the J.P. Morgan Healthcare Conference on January 15, 2026, at 8:15 a.m. Pacific Time. A live webcast will be available via the company's investor relations website. The presentation is attached as Exhibit 99.1. The company explicitly states that the information in this Item 7.01 and Exhibit 99.1 is furnished, not filed, and is not incorporated by reference into other filings unless expressly stated. The company undertakes no obligation to update or amend the attached materials.
Key Facts for Investor Verification
- Verify the date and time of the J.P. Morgan Healthcare Conference presentation (January 15, 2026, 8:15 a.m. PT).
- Access the live webcast or the attached presentation (Exhibit 99.1) via the company's investor relations website at https://ir.opusgtx.com.
- Note that the presentation materials are not considered "filed" for purposes of Section 18 of the Exchange Act and are not incorporated by reference into other SEC filings.
- Confirm that no financial results or updated guidance are contained within this specific 8-K filing text.